The Entrepreneurs Weekly
No Result
View All Result
Wednesday, July 2, 2025
  • Login
  • Home
  • BUSINESS
  • POLITICS
  • ENTREPRENEURSHIP
  • ENTERTAINMENT
Subscribe
The Entrepreneurs Weekly
  • Home
  • BUSINESS
  • POLITICS
  • ENTREPRENEURSHIP
  • ENTERTAINMENT
No Result
View All Result
The Entrepreneurs Weekly
No Result
View All Result
Home Business

FDA Panel Says Ingredient in Cold Medicine Is Ineffective | Entrepreneur

by Brand Post
September 12, 2023
in Business
0
FDA Panel Says Ingredient in Cold Medicine Is Ineffective | Entrepreneur
152
SHARES
1.9k
VIEWS
Share on FacebookShare on Twitter


Advisors for the US Food and Drug Administration (FDA) are sniffing their noses at a popular decongestant they claim doesn’t actually relieve the symptoms of a common cold.

On Tuesday, advisors to the FDA unanimously voted that phenylephrine, or “PE,” found in oral versions of Sudafed, Allegra, and Dayquil, is ineffective and should be pulled from the shelves.

The FDA must now determine whether they want to follow the panel’s recommendation. This major decision would mean companies such as Procter & Gamble and Johnson & Johnson would have to pull many of their products labeled “PE” out of drugstores.

“I think there’s a safety issue there,” Dr. Paul Pisaric of Archwell Health in Oklahoma told The Los Angeles Times. “I think this is a done deal as far as I’m concerned. It doesn’t work.”

A brief history of phenylephrine

In 2006, President Bush signed an act banning over-the-counter cold medicines with pseudoephedrine sales. The decongestant effectively clears stuffy noses but was also used in the illicit market to make methamphetamine.

Drug companies responded by replacing pseudoephedrine with a safer ingredient called phenylephrine. Customers could still buy products containing pseudoephedrine, but it was placed behind the counter at pharmacies and, in many cases, required a prescription from a doctor. Drugs with names such as Sudafed PE are much easier to purchase, making up the bulk of the $2.2 billion market for oral decongestants.

But doctors and concerned citizens have questioned PE’s effectiveness for years.

Panel votes no

Responding to continuing criticism of phenylephrine by doctors and citizen petitions, the Food and Drug Administration assembled a committee of experts to research whether the ingredient works.

The committee was asked to answer a single question: “Do the current scientific data that were presented support that the monograph dosage of orally administered phenylephrine is effective as a nasal decongestant?”

Its unanimous answer: “No.”

The committee also agreed that there is no more need for further studies. In other words, there decision was final.

“We really should not have products on the market that are not effective,” committee member Dr. Diane Ginsburg of the University of Texas at Austin College of Pharmacy told CNN.

Nasal sprays are okay

One caveat to the FDA committee’s recommendations. Drugs with phenylephrine that come as nasal sprays have been shown to be effective against congestion. But the oral versions, such as pills and syrups, not so much. Why? Some researchers believe that phenylephrine is metabolized by our bellies so well that not enough makes it into our bloodstream and up to our noses.



Source link

Tags: Business NewsColdentrepreneurFDAhealthIneffectiveIngredientmedicineNews and TrendsPanelScience & Technology

Related Posts

AI Startup TML From Ex-OpenAI Exec Mira Murati Pays 0,000 | Entrepreneur
Business

AI Startup TML From Ex-OpenAI Exec Mira Murati Pays $500,000 | Entrepreneur

July 1, 2025
Why Your Finance Team Needs an AI Strategy, Now | Entrepreneur
Business

Why Your Finance Team Needs an AI Strategy, Now | Entrepreneur

July 1, 2025
He Went From 1K in Debt to Teaching Others How to Succeed | Entrepreneur
Business

He Went From $471K in Debt to Teaching Others How to Succeed | Entrepreneur

July 1, 2025
  • Trending
  • Comments
  • Latest
Meet Amir Kenzo: A Well Known Musical Artist From Iran.

Meet Amir Kenzo: A Well Known Musical Artist From Iran.

August 21, 2022
Behind the Glamour: Bella Davis Opens Up About Overcoming Adversity in Modeling

Behind the Glamour: Bella Davis Opens Up About Overcoming Adversity in Modeling

April 20, 2024
Dr. Donya Ball: Pioneering Leadership Solutions for Tomorrow’s Challenges

Dr. Donya Ball: Pioneering Leadership Solutions for Tomorrow’s Challenges

May 10, 2024
Nasiyr Bey’s Journey from Brooklyn to Charlotte: The Entrepreneurial Path to Owning a Successful Cigar Lounge

Nasiyr Bey’s Journey from Brooklyn to Charlotte: The Entrepreneurial Path to Owning a Successful Cigar Lounge

August 8, 2024
Augmented.City Startup Developers Appeal To US Politicians With An Open Letter

Augmented.City Startup Developers Appeal To US Politicians With An Open Letter

0
U.S. High Court Snubs Challenge To State And Local Tax Deduction Cap

U.S. High Court Snubs Challenge To State And Local Tax Deduction Cap

0
GOP Lawmaker Blames Biden For Russia-Ukraine War: Putin ‘Could never have Invaded’

GOP Lawmaker Blames Biden For Russia-Ukraine War: Putin ‘Could never have Invaded’

0
Brad Winget’s Tips and Tricks on Having a Career in Real Estate

Brad Winget’s Tips and Tricks on Having a Career in Real Estate

0
AI Startup TML From Ex-OpenAI Exec Mira Murati Pays 0,000 | Entrepreneur

AI Startup TML From Ex-OpenAI Exec Mira Murati Pays $500,000 | Entrepreneur

July 1, 2025
Why Your Finance Team Needs an AI Strategy, Now | Entrepreneur

Why Your Finance Team Needs an AI Strategy, Now | Entrepreneur

July 1, 2025
He Went From 1K in Debt to Teaching Others How to Succeed | Entrepreneur

He Went From $471K in Debt to Teaching Others How to Succeed | Entrepreneur

July 1, 2025
How One Founder Is Rethinking Supplements With David Beckham | Entrepreneur

How One Founder Is Rethinking Supplements With David Beckham | Entrepreneur

July 1, 2025

The EW prides itself on assembling a proficient and dedicated team comprising seasoned journalists and editors. This collective commitment drives us to provide our esteemed readership with nothing short of the most comprehensive, accurate, and captivating news coverage available.

Transcending the bounds of Chicago to encompass a broader scope, we ensure that our audience remains well-informed and engaged with the latest developments, both locally and beyond.

NEWS

  • Business
  • Politics
  • Entrepreneurship
  • Entertainment
Instagram Facebook

© 2024 Entrepreneurs Weekly.  All Rights Reserved.

  • About Us
  • Advertise
  • Contact Us
No Result
View All Result
  • ENTREPRENEURSHIP
  • ENTERTAINMENT
  • POLITICS
  • BUSINESS
  • CONTACT US
  • ADVERTISEMENT

Copyright © 2024 - The Entrepreneurs Weekly

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In